Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3, 4-methylenedioxymethamphetamine (MDMA)

JM Paris, KA Cunningham - Brain research bulletin, 1992 - Elsevier

Author(s): Kathryn Ann Cunningham

Focus: MDMA


Abstract Systemic administration of 3, 4-methylenedioxymethamphetamine (MDMA) produces depletions of serotonin (5-HT) and its primary metabolite, 5-hydroxyindoleacetic acid (5-HIAA), decreases 5-HT reuptake sites and diminishes tryptophan hydroxylase …

Last updated: Jul 27, 2020